MIR98

Across TCGA pan-cancer cohorts, MIR98 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MIR98 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR98 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR98 expression acts as an unfavorable survival marker, although some lineages such as LIHC and STAD show a favorable association.

LUSC, PAAD, and MESO are the cancer types where MIR98 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	All	0.236	0.432	<.001	130	view →
PAAD	OS	Tertile	II,III,IV	0.411	0.624	<.001	90	view →
MESO	OS	Tertile	IV	0.077	0.638	<.001	39	view →
LIHC	DFS	Tertile	All	0.584	0.268	.005	36	view →
STAD	DFS	Median	III,IV	0.668	0.513	.011	35	view →
THCA	DFS	Tertile	II,III,IV	1.000	0.694	.020	27	view →
READ	DFS	Tertile	IV	0.179	0.936	.010	18	view →
BLCA	DFS	Tertile	III,IV	0.590	0.317	.026	15	view →
CESC	OS	Tertile	All	0.708	0.822	.029	12	view →
DLBC	DFS	Quartile	III,IV	0.070	0.833	.014	11	view →
SKCM	OS	Tertile	IV	0.247	0.721	.038	9	view →
PCPG	OS	Tertile	All	0.806	0.981	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MIR98–LUSC (DFS)

Open the LUSC breakdown →